SEC Tracker
Get the app

Sangamo Therapeutics SGMOQ

Sangamo Therapeutics: reports quarterly results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Sangamo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. enGene Therapeutics ENGN public float $154M, Apr 30, 2025, over 18 months old
  2. Alpha Cognition ACOG public float $149M, Jun 30, 2025
  3. Voyager Therapeutics VYGR public float $144M, Jun 30, 2025
  4. Lineage Cell Therapeutics LCTX public float $162M, Jun 30, 2025
  5. 4D Molecular Therapeutics FDMT public float $166M, Jun 30, 2025